Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report

Concurrent hypereosinophilic syndrome and deep vein thrombosis after Pfizer‐BioNTech COVID‐19 vaccination: A case report

Abstract Herein, we report a case of eosinophilia syndrome and deep vein thrombosis presenting concurrently after the administration of the BNT162b2 mRNA‐based coronavirus disease 2019 (COVID‐19) vaccine. It is extremely rare to have both hypereosinophilic syndrome and deep vein thrombosis simultane...

Full description

Saved in:
Bibliographic Details
Main Authors: Shungo Yano, Taiju Miyagami, Takayuki Furusaka, Nagamasa Kano, Toshio Naito
Format: Article
Language:English
Published: Wiley 2023-03-01
Series:Clinical Case Reports
Subjects:
adverse events following immunization
COVID‐19
case report
deep vein thrombosis
hypereosinophilic syndrome
Online Access:https://doi.org/10.1002/ccr3.7001
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Herein, we report a case of eosinophilia syndrome and deep vein thrombosis presenting concurrently after the administration of the BNT162b2 mRNA‐based coronavirus disease 2019 (COVID‐19) vaccine. It is extremely rare to have both hypereosinophilic syndrome and deep vein thrombosis simultaneously. Both are serious diseases and should be treated with caution.
ISSN:2050-0904

Similar Items